Schonfeld Strategic Advisors’s RAPT Therapeutics RAPT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q1 | – | Sell |
-13,830
| Closed | -$2.75M | – | 2125 |
|
|
2023
Q4 | $2.75M | Sell |
13,830
-3,051
| -18% | -$607K | 0.02% | 640 |
|
|
2023
Q3 | $2.24M | Buy |
16,881
+7,256
| +75% | +$965K | 0.02% | 691 |
|
|
2023
Q2 | $1.44M | Buy |
+9,625
| New | +$1.44M | 0.01% | 861 |
|
|
2023
Q1 | – | Sell |
-35,234
| Closed | -$5.58M | – | 2430 |
|
|
2022
Q4 | $5.58M | Buy |
35,234
+21,948
| +165% | +$3.48M | 0.05% | 449 |
|
|
2022
Q3 | $2.56M | Sell |
13,286
-4,819
| -27% | -$928K | 0.02% | 768 |
|
|
2022
Q2 | $2.64M | Buy |
18,105
+5,480
| +43% | +$800K | 0.03% | 619 |
|
|
2022
Q1 | $2.22M | Sell |
12,625
-4,022
| -24% | -$708K | 0.02% | 646 |
|
|
2021
Q4 | $4.89M | Sell |
16,647
-7,907
| -32% | -$2.32M | 0.04% | 430 |
|
|
2021
Q3 | $6.1M | Buy |
24,554
+313
| +1% | +$77.7K | 0.06% | 349 |
|
|
2021
Q2 | $6.16M | Buy |
24,241
+15,450
| +176% | +$3.93M | 0.07% | 386 |
|
|
2021
Q1 | $1.56M | Sell |
8,791
-6,017
| -41% | -$1.07M | 0.02% | 708 |
|
|
2020
Q4 | $2.34M | Sell |
14,808
-16,383
| -53% | -$2.59M | 0.03% | 534 |
|
|
2020
Q3 | $8.04M | Buy |
31,191
+24,098
| +340% | +$6.21M | 0.15% | 177 |
|
|
2020
Q2 | $1.65M | Buy |
+7,093
| New | +$1.65M | 0.04% | 430 |
|